Efficacy and Safety of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma with Extranodal Involvement: A Single-Arm, Prospective Phase II Trial
Autor: | Yang, Tao *, Li, Jun *, Zhang, Wenjun *, Guo, Bingling *, Hu, Chongling *, Quan, Xi *, Zeng, Chensi *, Ding, Yao *, Huang, Dehong *, Xiao, Chunyan *, Liu, Jun *, Wu, Jing *, Wang, Chaoyu *, Liang, Xiping *, Zhang, Lingqian *, Yang, Zailin *, Liang, Shunsi *, Hu, Renzhi *, Liu, Tingting *, Li, Qiying *, Li, Jieping *, Nan, Yingyu *, Xiang, Ying *, Liu, Yao * |
---|---|
Zdroj: | In Blood 15 November 2022 140 Supplement 1:9540-9541 |
Databáze: | ScienceDirect |
Externí odkaz: |